Dolutegravir intermediate-1 structure
|
Common Name | Dolutegravir intermediate-1 | ||
|---|---|---|---|---|
| CAS Number | 1335210-23-5 | Molecular Weight | 315.276 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 474.1±45.0 °C at 760 mmHg | |
| Molecular Formula | C13H17NO8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 240.5±28.7 °C | |
Use of Dolutegravir intermediate-1Dolutegravir intermediate-1 is a novel synthetic intermediate of dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-l infection. |
| Name | 2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-, 2-methyl ester |
|---|---|
| Synonym | More Synonyms |
| Description | Dolutegravir intermediate-1 is a novel synthetic intermediate of dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-l infection. |
|---|---|
| Related Catalog | |
| References |
[1]. Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2. |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 474.1±45.0 °C at 760 mmHg |
| Molecular Formula | C13H17NO8 |
| Molecular Weight | 315.276 |
| Flash Point | 240.5±28.7 °C |
| Exact Mass | 315.095428 |
| PSA | 113.29000 |
| LogP | -1.00 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.536 |
| Storage condition | 2-8℃ |
| 1-(2,2-Dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydro-3-pyridinecarboxylic acid |
| 2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-, 2-methyl ester |
| 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid |
| Dolutegravir intermediate-1 |
| 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester |